title: Metabolomic effects of xylitol and fluoride on plaque biofilm in vivo.
abstract: Dental caries is initiated by demineralization of the tooth surface through acid production from sugar by plaque biofilm. Fluoride and xylitol have been used worldwide as caries-preventive reagents, based on in vitro-proven inhibitory mechanisms on bacterial acid production. We attempted to confirm the inhibitory mechanisms of fluoride and xylitol in vivo by performing metabolome analysis on the central carbon metabolism in supragingival plaque using the combination of capillary electrophoresis and a time-of-flight mass spectrometer. Fluoride (225 and 900 ppm F(-)) inhibited lactate production from 10% glucose by 34% and 46%, respectively, along with the increase in 3-phosphoglycerate and the decrease in phosphoenolpyruvate in the EMP pathway in supragingival plaque. These results confirmed that fluoride inhibited bacterial enolase in the EMP pathway and subsequently repressed acid production in vivo. In contrast, 10% xylitol had no effect on acid production and the metabolome profile in supragingival plaque, although xylitol 5-phosphate was produced. These results suggest that xylitol is not an inhibitor of plaque acid production but rather a non-fermentative sugar alcohol. Metabolome analyses of plaque biofilm can be applied for monitoring the efficacy of dietary components and medicines for plaque biofilm, leading to the development of effective plaque control.
authors.affiliation: Division of Oral Ecology and Biochemistry, Department of Oral Biology, Tohoku University Graduate School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. nobu-t@dent.tohoku.ac.jp
authors.forename: N
authors.initials: N
authors.lastname: Takahashi
authors.forename: J
authors.initials: J
authors.lastname: Washio
mesh_terms: D000328:Adult; D002327:Cariostatic Agents / Q000378:metabolism*; D003773:Dental Plaque / Q000378:metabolism*; D019075:Electrophoresis, Capillary; D005260:Female; D005459:Fluorides / Q000378:metabolism*; D006019:Glycolysis; D006801:Humans; D019344:Lactic Acid / Q000378:metabolism; D008297:Male; D055442:Metabolome; D010428:Pentosephosphates / Q000378:metabolism; D010728:Phosphoenolpyruvate / Q000378:metabolism; D010751:Phosphopyruvate Hydratase / Q000037:antagonists & inhibitors; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods; D013295:Streptococcus mutans / Q000378:metabolism; D014993:Xylitol / Q000378:metabolism*; D055815:Young Adult
chemical_list: D002327:Cariostatic Agents; D010428:Pentosephosphates; D019344:Lactic Acid; C064260:xylitol 5-phosphate; D010728:Phosphoenolpyruvate; D010751:Phosphopyruvate Hydratase; D005459:Fluorides; D014993:Xylitol